Page 13 - Heart Failure Clinical Guidelines

13

5. Myectomy referral
a) HF symptoms from LVOTO that is not amenable to beta blockers or Calcium channel blockers
b) LVOTO gradient >75mmHg

C. Long-Term Follow-up Schedule for Hypertrophic Cardiomyopathy

1. Asymptomatic with No LVOTO or mid-cavitary gradient and no risk factors for Sudden Death
1. F/U q6 months (q3 months if <3yo)
2. Echo q6 months
3. CBC, BMP, BNP q 6 months
4. EKG q6 months
5. Holter/Event Monitor q1-2 years
6. Exercise with Metabolic q3 years
2. Asymptomatic with LVOTO or mid-cavitary gradient or risk factors for sudden death
1. F/U q3-6 months (q3 months if <3yo)
2. Echo q6 months
3. CBC, BMP, BNP q 6 months
4. EKG q6 months
5. Holter/Event Monitor q1 year
6. Exercise with Metabolic q2 years
3. Symptomatic or with LVOTO or mid-cavitary gradient or risk factors for sudden death
1. F/U q1-3 months
2. Echo q1-3 months
3. CBC, BMP, BNP q 1-3 months
4. EKG q3 months
5. Holter/Event Monitor q1 year
6. Exercise Test q 1-2 years